Yongzhe Li Selected Research

Yongzhe Li Research Topics

Disease

18	Autoimmune Diseases (Autoimmune Disease) 04/2024 - 06/2009
16	COVID-19 04/2024 - 01/2020
14	Systemic Lupus Erythematosus (Libman-Sacks Disease) 04/2023 - 06/2009
12	Inflammation (Inflammations) 04/2024 - 07/2014
11	Rheumatoid Arthritis 05/2021 - 01/2010
10	Biliary Liver Cirrhosis (Primary Biliary Cirrhosis) 04/2024 - 01/2010
10	Immunoglobulin G4-Related Disease 04/2023 - 05/2014
10	Dermatomyositis (Dermatopolymyositis) 03/2023 - 01/2014
9	Neoplasms (Cancer) 06/2023 - 01/2019
7	Systemic Scleroderma (Systemic Sclerosis) 10/2023 - 04/2013
7	Liver Diseases (Liver Disease) 10/2023 - 01/2010
7	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 12/2020 - 11/2015
6	Glioma (Gliomas) 06/2023 - 11/2017
6	Interstitial Lung Diseases (Interstitial Lung Disease) 11/2022 - 01/2014
6	Takayasu Arteritis (Arteritis, Takayasu's) 12/2021 - 01/2017
6	Thrombosis (Thrombus) 10/2020 - 04/2016
5	Polymyositis 01/2022 - 02/2016
5	Crohn Disease (Crohn's Disease) 10/2020 - 10/2015
4	Fibrosis (Cirrhosis) 07/2023 - 01/2021
4	Sjogren's Syndrome (Sjogren Syndrome) 04/2023 - 01/2010
4	Myositis (Idiopathic Inflammatory Myopathies) 03/2021 - 04/2017
4	Vasculitis (Vasculitides) 01/2021 - 03/2015
4	Ulcerative Colitis 10/2020 - 01/2015
4	Genetic Predisposition to Disease (Genetic Predisposition) 11/2018 - 05/2012
3	Glioblastoma (Glioblastoma Multiforme) 06/2023 - 11/2017
3	Behcet Syndrome (Behcet's Syndrome) 01/2021 - 01/2021
3	Connective Tissue Diseases (Connective Tissue Disease) 04/2020 - 01/2019
3	Lupus Nephritis 12/2016 - 03/2011
2	Coronary Stenosis (Coronary Artery Stenosis) 12/2023 - 12/2020
2	Coronary Artery Disease (Coronary Atherosclerosis) 12/2023 - 12/2023
2	Hepatitis B 10/2023 - 01/2010
2	Pancreatic Neoplasms (Pancreatic Cancer) 04/2023 - 12/2022
2	Tuberculosis (Tuberculoses) 01/2023 - 02/2018
2	Irritable Bowel Syndrome (Syndrome, Irritable Bowel) 01/2022 - 12/2018
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2021 - 05/2017
2	Infections 12/2020 - 11/2020
2	Critical Illness (Critically Ill) 12/2020 - 10/2020
2	Cytokine Release Syndrome 11/2020 - 10/2020
2	Venous Thrombosis (Deep-Vein Thrombosis) 08/2019 - 01/2018
2	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 02/2018 - 10/2015
2	Central Nervous System Lupus Vasculitis 01/2015 - 03/2011
2	Autoimmune Hepatitis 11/2011 - 01/2010
1	Demyelinating Diseases (Demyelinating Disease) 04/2024
1	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 01/2024
1	Type 2 Diabetes Mellitus (MODY) 11/2023

Drug/Important Bio-Agent (IBA)

34	Biomarkers (Surrogate Marker)IBA 12/2023 - 06/2009
23	AntibodiesIBA 10/2023 - 11/2011
18	Immunoglobulin G (IgG)IBA 04/2023 - 05/2014
16	Proteins (Proteins, Gene)FDA Link 01/2023 - 06/2009
16	AutoantibodiesIBA 01/2022 - 03/2011
8	Antiphospholipid AntibodiesIBA 12/2020 - 11/2015
7	CytokinesIBA 01/2024 - 05/2014
6	COVID-19 VaccinesIBA 04/2024 - 01/2023
6	ProteomeIBA 10/2023 - 01/2015
5	VaccinesIBA 04/2024 - 12/2020
5	Immunoglobulin M (IgM)IBA 01/2021 - 04/2017
4	Immunoglobulins (Immunoglobulin)IBA 04/2024 - 01/2021
4	EnzymesIBA 03/2023 - 11/2013
4	Peptides (Polypeptides)IBA 05/2021 - 01/2018
4	AutoantigensIBA 08/2020 - 01/2010
3	LipidsIBA 12/2023 - 01/2016
3	Interleukin-6 (Interleukin 6)IBA 03/2023 - 11/2020
3	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 01/2021 - 10/2015
3	Prothrombin (Factor II)IBA 12/2020 - 04/2017
3	Immunoglobulin A (IgA)IBA 12/2020 - 04/2017
3	Glycoproteins (Glycoprotein)IBA 12/2020 - 10/2015
3	ImmunosorbentsIBA 12/2020 - 11/2013
3	Blood Proteins (Serum Proteins)IBA 11/2020 - 06/2009
2	LDL CholesterolIBA 12/2023 - 12/2021
2	Lipoprotein(a)IBA 12/2023 - 12/2021
2	Temozolomide (Temodar)FDA LinkGeneric 06/2023 - 11/2017
2	Indicators and Reagents (Reagents)IBA 04/2023 - 12/2021
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 03/2023 - 01/2021
2	Interferon-gamma (Interferon, gamma)IBA 01/2022 - 10/2020
2	Messenger RNA (mRNA)IBA 01/2022 - 01/2015
2	Immune Checkpoint InhibitorsIBA 01/2022 - 01/2022
2	Phosphopyruvate Hydratase (Enolase)IBA 05/2021 - 01/2019
2	fibrin fragment D (D-dimer)IBA 02/2021 - 01/2021
2	Anti-Citrullinated Protein AntibodiesIBA 01/2021 - 01/2014
2	EpitopesIBA 01/2021 - 12/2016
2	Immunosuppressive Agents (Immunosuppressants)IBA 01/2021 - 11/2015
2	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2021 - 08/2019
2	PhosphatidylserinesIBA 12/2020 - 01/2018
2	Phospholipids (Phosphatides)FDA LinkGeneric 10/2020 - 08/2019
2	HLA-B Antigens (HLA-B)IBA 01/2018 - 01/2017
2	mesoglycanIBA 01/2017 - 03/2015
2	I-kappa B KinaseIBA 01/2015 - 01/2015
2	Phosphotransferases (Kinase)IBA 01/2015 - 01/2015
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2014 - 01/2014
2	cyclic citrullinated peptideIBA 01/2014 - 01/2014
1	lipoarabinomannan (LAM)IBA 04/2024
1	oxidized low density lipoproteinIBA 12/2023
1	Glucose (Dextrose)FDA LinkGeneric 12/2023
1	Nonesterified Fatty Acids (NEFA)IBA 12/2023
1	Triglycerides (Triacylglycerol)IBA 12/2023
1	RNA (Ribonucleic Acid)IBA 12/2023

Therapy/Procedure

8	Therapeutics 01/2023 - 11/2017
4	Aftercare (After-Treatment) 10/2022 - 03/2011
3	Drug Therapy (Chemotherapy) 06/2023 - 11/2017
3	Lasers (Laser) 10/2011 - 03/2011